Document Detail


Effects of a cardiac glycoside in combination with propranolol on the ischemic heart of conscious dogs.
MedLine Citation:
PMID:  624166     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of coronary occlusion and of subsequent propranolol and ouabain administration were examined in 12 conscious dogs. Overall left ventricular (LV) function was assessed by measurement of LV pressure and dP/dt, and regional myocardial function was assessed by measurements of segment length (SL), velocity of SL shortening and regional myocardial "work," i.e., pressure-length loops in normal and moderately and severely ischemic zones. Regional intramyocardial electrograms were measured at the same sites as function along with regional myocardial blood flow as determined by the radioactive microsphere technique. Coronary occlusion resulted in graded loss of function from the normal to severely ischemic zones, along with graded flow reductions and graded elevation of the ST segment. Propranolol, 1 mg/kg, depressed overall LV function and function in the normal zone more than in ischemic zones. Propranolol reduced flow to the normal zone and increased flow to ischemic zones, while not affecting ST-segment elevation significantly. In the presence of occlusion and propranolol, ouabain, 20 microgram/kg, improved overall LV function as well as regional function in the normal, moderately ischemic and severely ischemic zones. In addition, ouabain reduced ST elevation and increased blood flow further in moderately and severely ischemic zones. Most strikingly, ouabain returned normal systolic shortening to eight severely ischemic segments which were previously akinetic.
Authors:
S F Vatner; H Baig; W T Manders; P A Murray
Related Documents :
4052276 - Effect of early treatment with propranolol on left ventricular function four weeks afte...
998506 - Propranolol-induced reduction of signs of ischemic injury during acute myocardial infar...
9495866 - The enantiomer-specific kinetics and dynamics of verapamil after rapid intravenous admi...
6133636 - Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with ...
22789446 - Plasma adiponectin levels in relation to prognosis in patients with angiographic corona...
1728496 - Role of implantable cardioverter defibrillator therapy in the management of high-risk p...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Circulation     Volume:  57     ISSN:  0009-7322     ISO Abbreviation:  Circulation     Publication Date:  1978 Mar 
Date Detail:
Created Date:  1978-04-17     Completed Date:  1978-04-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  568-75     Citation Subset:  AIM; IM; S    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Pressure / drug effects
Cardiac Output / drug effects
Coronary Circulation / drug effects
Coronary Disease / physiopathology*
Coronary Vessels / physiopathology
Dogs
Electrocardiography
Heart Rate / drug effects
Ouabain / pharmacology*
Propranolol / pharmacology*
Chemical
Reg. No./Substance:
525-66-6/Propranolol; 630-60-4/Ouabain

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hemodynamic effects of nitroprusside and hydralazine in experimental cardiac tamponade.
Next Document:  Beneficial effect of physical training on blood flow to myocardium perfused by chronic collaterals i...